⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8273222 | 1.00 | — | — | |
| SCHEMBL14040908 | 1.00 | — | — | |
| SCHEMBL22924844 | 0.85 | — | — | |
| SCHEMBL18570284 | 0.79 | — | — | |
| SCHEMBL22924841 | 0.79 | — | — | |
| SCHEMBL237033 | 0.79 | — | — | |
| SCHEMBL237034 | 0.79 | — | — | |
| SCHEMBL20787016 | 0.78 | ALDH1A1 (0.32) | — | |
| SCHEMBL13980458 | 0.78 | — | — | |
| SCHEMBL12831630 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230286942-A1 | NEW PqsR INVERSE AGONISTS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2023-09-14 | — | — | US | disclosed |
| EP-3042719-B1 | USE OF A CATALYST FOR FIXED BED ANILINE RECTIFICATION RESIDUE RECYCLING | WANHUA CHEMICAL GROUP CO LTD (CN) | 2023-07-12 | — | — | EP | disclosed |
| US-20230192592-A1 | MONOMER AND POLYMER, COMPENSATION FILM, OPTICAL FILM, AND DISPLAY DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20220162246-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-26 | — | — | US | disclosed |
| WO-2021239117-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | CULLGEN (SHANGHAI) , INC. (CN) | 2021-12-02 | — | — | WO | disclosed |
| WO-2021071843-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | Pipeline Therapeutics, Inc. (US) | 2021-04-15 | — | — | WO | disclosed |
| EP-3649101-B1 | METHOD FOR THE PREPARATION OF 4-(HEPTAFLUORO-2-PROPYL) ANILINES | LONZA SOLUTIONS AG (CH) | 2021-03-24 | — | — | EP | disclosed |
| US-10937976-B2 | Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-03-02 | — | — | US | disclosed |
| US-10662154-B2 | Methods of manufacture of 2-aryl-3,3-bis(4-hydroxyaryl)phthalimidines, and polymers derived therefrom | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-05-26 | — | — | US | disclosed |
| US-20190256659-A1 | POLYMER, FILM INCLUDING THE POLYMER, AND DISPLAY DEVICE INCLUDING THE FILM | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-22 | — | — | US | disclosed |
| US-9611231-B2 | Method for preparing 3-trifluoromethyl chalcones | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-04-04 | — | — | US | disclosed |
| US-9550724-B2 | Diphenylamine compounds and production method thereof | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2017-01-24 | — | — | US | disclosed |
| US-20140194385-A1 | BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF | QPEX BIOPHARMA, INC. | 2014-07-10 | — | — | US | disclosed |
| EP-2434343-A1 | Resist composition, resist film therefrom and method of forming pattern therewith | Fujifilm Corporation (JP) | 2012-03-28 | — | — | EP | disclosed |
| EP-2099759-B1 | ANTIBACTERIAL QUINOLINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010078427-A1 | SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| EP-1712595-B1 | AZO COMPOUND AND POLARIZING FILM AND POLARIZING PLATE EACH CONTAINING THE SAME | NIPPON KAYAKU KK (JP) | 2009-04-29 | — | — | EP | disclosed |
| EP-1238970-B9 | CYCLOAMINE CCR5 RECEPTOR ANTAGONISTS | TEIJIN LTD (JP) | 2007-05-09 | — | — | EP | disclosed |
| WO-2004037176-A2 | QUINAZOLINONES AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-05-06 | — | — | WO | disclosed |
| WO-2003047577-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES | EISAI CO LTD (JP) | 2003-06-12 | — | — | WO | disclosed |